These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23167815)

  • 41. Renal graft failure due to type 1 primary hyperoxaluria.
    Riksen NP; Timmers HJ; Assmann KJ; Huysmans FT
    Neth J Med; 2002 Nov; 60(10):407-10. PubMed ID: 12607592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Which transplantation strategies in primary hyperoxaluria type 1?].
    De Pauw L; Watts RW; Danpure CJ; Toussaint C
    Nephrologie; 1991; 12(3):147-9. PubMed ID: 1922655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].
    Jungers P; Joly D; Blanchard A; Courbebaisse M; Knebelmann B; Daudon M
    Nephrol Ther; 2008 Jul; 4(4):231-55. PubMed ID: 18499551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004.
    Jamieson NV;
    Am J Nephrol; 2005; 25(3):282-9. PubMed ID: 15961948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of oxalosis cardiomyopathy after combined liver and kidney transplantation.
    Detry O; Honoré P; DeRoover A; Trimeche M; Demoulin JC; Beaujean M; Moonen M; Godon JP; Boniver J; Jacquet N; Meurisse M
    Transpl Int; 2002 Jan; 15(1):50-2. PubMed ID: 11875614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Iterative fractures in type I primary hyperoxaluria. Report of 2 cases].
    Levadoux M; Picon G; Gadea J; Delarue A; Jouve JL; Bollini G
    Rev Chir Orthop Reparatrice Appar Mot; 1999 Mar; 85(1):75-80. PubMed ID: 10327470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria.
    Monico CG; Milliner DS
    Liver Transpl; 2001 Nov; 7(11):954-63. PubMed ID: 11699031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary hyperoxaluria in infants: medical, ethical, and economic issues.
    Cochat P; Koch Nogueira PC; Mahmoud MA; Jamieson NV; Scheinman JI; Rolland MO
    J Pediatr; 1999 Dec; 135(6):746-50. PubMed ID: 10586179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The Hyperoxalurias].
    Marangella M; Petrarulo M; Bermond F; Marcuccio C; Vitale C
    G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary hyperoxaluria: the pediatric nephrologist's point of view.
    Ben-Shalom E; Garrelfs SF; Groothoff JW
    Clin Kidney J; 2022 May; 15(Suppl 1):i23-i28. PubMed ID: 35592624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic and therapeutic strategies in hyperoxaluria: a plea for early intervention.
    Hoppe B; Leumann E
    Nephrol Dial Transplant; 2004 Jan; 19(1):39-42. PubMed ID: 14671036
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal transplantation in secondary oxalosis.
    Roberts RA; Sketris IS; MacDonald AS; Belitsky P
    Transplantation; 1988 May; 45(5):985-6. PubMed ID: 3285545
    [No Abstract]   [Full Text] [Related]  

  • 53. Primary hyperoxaluria: the adult nephrologist's point of view.
    Moochhala SH; Worcester EM
    Clin Kidney J; 2022 May; 15(Suppl 1):i29-i32. PubMed ID: 35711295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary hyperoxaluria in adults and children: a nationwide cohort highlights a persistent diagnostic delay.
    Pszczolinski R; Acquaviva C; Berrahal I; Biebuyck N; Burtey S; Clabault K; Dossier C; Guillet M; Hemery F; Letavernier E; Rousset-Rouvière C; Bacchetta J; Moulin B
    Clin Kidney J; 2024 May; 17(5):sfae099. PubMed ID: 38737343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias.
    Moya-Garzon MD; Gomez-Vidal JA; Alejo-Armijo A; Altarejos J; Rodriguez-Madoz JR; Fernandes MX; Salido E; Salido S; Diaz-Gavilan M
    J Pers Med; 2021 Jan; 11(2):. PubMed ID: 33513899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutaneous oxalosis presenting as subcutaneous nodules in a dialysis patient.
    Ting SW; Ger TY; Kuo G
    Kidney Int; 2020 May; 97(5):1063. PubMed ID: 32331586
    [No Abstract]   [Full Text] [Related]  

  • 57. [Revolution in the field of primary and secondary hyperoxalurias: Stay tuned!].
    Bacchetta J; Cochat P
    Med Sci (Paris); 2023 Mar; 39(3):262-264. PubMed ID: 36943123
    [No Abstract]   [Full Text] [Related]  

  • 58. Primary and secondary hyperoxaluria: Understanding the enigma.
    Bhasin B; Ürekli HM; Atta MG
    World J Nephrol; 2015 May; 4(2):235-44. PubMed ID: 25949937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.
    Glew RH; Sun Y; Horowitz BL; Konstantinov KN; Barry M; Fair JR; Massie L; Tzamaloukas AH
    World J Nephrol; 2014 Nov; 3(4):122-42. PubMed ID: 25374807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AGXT2: a promiscuous aminotransferase.
    Rodionov RN; Jarzebska N; Weiss N; Lentz SR
    Trends Pharmacol Sci; 2014 Nov; 35(11):575-82. PubMed ID: 25294000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.